Eosinophilic granulomatosis with polyangiitis and its association with montelukast: a case-based review
Clinical Rheumatology · 2024
DOI: 10.1007/s10067-024-07000-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Rheumatology, 2024. Verfasst von Grace Alexander und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, IA, USA. Hauptthemen laut MEDLINE: Sulfides, Quinolines, Cyclopropanes, Acetates. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Kelting fund.
Abstract (Originalsprache)
The association between the use of certain medications (including sulfonamides, hydralazine, and procainamide) and the occurrence of drug-induced lupus or hepatitis is well established. More recently, cases of immune-related adverse events ranging from inflammatory polyarthritis to necrotizing myositis in patients taking checkpoint inhibitors have been reported. However, data linking drugs to systemic vasculitis are scarce and at times debatable. Propylthiouracil, hydralazine, and minocycline have been associated with rare cases of ANCA-associated syndromes, including life-threatening pulmonary-renal syndromes and systemic polyarteritis nodosa-like diseases. Eosinophilic granulomatosis with polyangiitis (EGPA) has been reported in patients taking leukotriene inhibitors. Since the link between the use of leukotriene inhibitors and occurrence of EGPA remains highly controversial, we performed a literature review for cases of EGPA in patients taking montelukast without prior history of oral corticosteroid use. We found 24 cases, along with our own two cases described, making 26 cases in total. The mean age was 43 and a majority (18/26) were female. In majority of cases EGPA-like disease never relapsed after they were taken off leukotriene inhibitors suggesting a clear causal relationship between the use of these drugs and occurrence of eosinophil-rich systemic EGPA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Iowa Hospitals & Clinics, Iowa City, IA, USA.
- Department of Pathology, University of Hospitals & Clinics, Iowa City, IA, USA.
- Department of Internal Medicine, Division of Immunology, University of Iowa Hospitals & Clinics, Iowa City, IA, USA. petar-lenert@uiowa.edu.
Förderung
- Kelting fund
Zitieren
APA
Alexander, G., Moore, S. A., & Lenert, P. S. (2024). Eosinophilic granulomatosis with polyangiitis and its association with montelukast: a case-based review. Clinical Rheumatology. https://doi.org/10.1007/s10067-024-07000-8
Vancouver
Alexander G, Moore SA, Lenert PS. Eosinophilic granulomatosis with polyangiitis and its association with montelukast: a case-based review. Clinical Rheumatology. 2024. doi:10.1007/s10067-024-07000-8
BibTeX
@article{Alexander2024,
author = {Alexander, Grace and Moore, Steven A and Lenert, Petar S},
title = {Eosinophilic granulomatosis with polyangiitis and its association with montelukast: a case-based review},
journal = {Clinical Rheumatology},
year = {2024},
doi = {10.1007/s10067-024-07000-8}
}
EUVIMED